Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Filibuvir

Generic Name: Filibuvir

Drug Type: Small Molecule

Chemical Formula: C_₂₉H_₃₇N_₅O_₃

CAS Number: 877130-28-4

Unique Ingredient Identifier: 198J479Y2L

Overview

Filibuvir has been used in trials studying the treatment of Hepatitis, Hepatitis C, and Chronic Hepatitis C.

Background

Filibuvir has been used in trials studying the treatment of Hepatitis, Hepatitis C, and Chronic Hepatitis C.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Drug Interaction Study Of Filibuvir With Methadone Among Subjects On Chronic Methadone Maintenance

Phase 1

Completed

Posted: 2010/09/28

Sponsor:Pfizer

ID:NCT01210404

Filibuvir In Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Subjects

Phase 2

Completed

Posted: 2009/09/30

Sponsor:Pfizer

ID:NCT00987337

Investigation Of The Effect Of Steady State Filibuvir On The Pharmacokinetics Of Oral Contraceptives (Levonorgestrel And Ethinyl Estradiol)

Phase 1

Completed

Posted: 2009/06/11

Sponsor:Pfizer

ID:NCT00918476

A Dose Ranging Study Of PF-00868554 In Combination With PEGASYS And COPEGUS In Patients With Chronic Hepatitis C Genotype 1 Infection

Phase 2

Completed

Posted: 2008/07/22

Sponsor:Pfizer

ID:NCT00720434

A Phase 1 Study Of PF-00868554 In Hepatitis C Virus (HCV) Positive Patients

Phase 1

Completed

Posted: 2007/03/08

Sponsor:Pfizer

ID:NCT00445315

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy